FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2177788247> ?p ?o ?g. }

• W2177788247 abstract "In patients with discordance between low-density lipoprotein (LDL) cholesterol and LDL particle (LDL-P) concentrations, cardiovascular risk more closely correlates with LDL-P.We investigated the effect of alirocumab, a fully human monoclonal antibody to proprotein convertase subtilisin/kexin type 9, on lipoprotein particle concentration and size in hypercholesterolemic patients, using nuclear magnetic resonance spectroscopy. Plasma samples were collected from patients receiving alirocumab 150 mg every 2 weeks (n=26) or placebo (n=31) during a phase II, double-blind, placebo-controlled trial in patients (LDL cholesterol ≥100 mg/dL) on a stable atorvastatin dose. In this post hoc analysis, percentage change in concentrations of LDL-P, very-low-density lipoprotein particles, and high-density lipoprotein particles from baseline to week 12 was determined by nuclear magnetic resonance. Alirocumab significantly reduced mean concentrations of total LDL-P (-63.3% versus -1.0% with placebo) and large (-71.3% versus -21.8%) and small (-54.0% versus +17.8%) LDL-P subfractions and total very-low-density lipoprotein particle concentrations (-36.4% versus +33.4%; all P<0.01). Total high-density lipoprotein particles increased with alirocumab (+11.2% versus +1.4% with placebo; P<0.01). There were greater increases in large (44.6%) versus medium (17.7%) or small high-density lipoprotein particles (2.8%) with alirocumab. LDL-P size remained relatively unchanged in both groups; however, very-low-density and high-density lipoprotein particle sizes increased to a significantly greater extent with alirocumab.Alirocumab significantly reduced LDL-C and LDL-P concentrations in hypercholesterolemic patients receiving stable atorvastatin therapy. These findings may be of particular relevance to patients with discordant LDL-C and LDL-P concentrations.URL: https://clinicaltrials.gov. Unique identifier: NCT01288443." @default.
• W2177788247 created "2016-06-24" @default.
• W2177788247 creator A5010453470 @default.
• W2177788247 creator A5019163181 @default.
• W2177788247 creator A5032891959 @default.
• W2177788247 creator A5054320288 @default.
• W2177788247 creator A5061314561 @default.
• W2177788247 creator A5077276053 @default.
• W2177788247 creator A5082003758 @default.
• W2177788247 creator A5085882168 @default.
• W2177788247 date "2015-10-29" @default.
• W2177788247 modified "2023-10-07" @default.
• W2177788247 title "Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy" @default.
• W2177788247 cites W181225814 @default.
• W2177788247 cites W1982456918 @default.
• W2177788247 cites W1984875752 @default.
• W2177788247 cites W1990092121 @default.
• W2177788247 cites W1994137263 @default.
• W2177788247 cites W2004247699 @default.
• W2177788247 cites W2006312678 @default.
• W2177788247 cites W2012344261 @default.
• W2177788247 cites W2019071303 @default.
• W2177788247 cites W2023797086 @default.
• W2177788247 cites W2041312494 @default.
• W2177788247 cites W2053585701 @default.
• W2177788247 cites W2056939999 @default.
• W2177788247 cites W2059881177 @default.
• W2177788247 cites W2096075279 @default.
• W2177788247 cites W2101244337 @default.
• W2177788247 cites W2101702589 @default.
• W2177788247 cites W2107424758 @default.
• W2177788247 cites W2107443630 @default.
• W2177788247 cites W2108840705 @default.
• W2177788247 cites W2123027967 @default.
• W2177788247 cites W2124931981 @default.
• W2177788247 cites W2128030263 @default.
• W2177788247 cites W2130190789 @default.
• W2177788247 cites W2141898196 @default.
• W2177788247 cites W2146262274 @default.
• W2177788247 cites W2148577580 @default.
• W2177788247 cites W2152354184 @default.
• W2177788247 cites W2163381397 @default.
• W2177788247 cites W2164089346 @default.
• W2177788247 cites W2169338584 @default.
• W2177788247 cites W2607031541 @default.
• W2177788247 cites W2735197557 @default.
• W2177788247 cites W4238251256 @default.
• W2177788247 doi "https://doi.org/10.1161/jaha.115.002224" @default.
• W2177788247 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4845239" @default.
• W2177788247 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26586732" @default.
• W2177788247 hasPublicationYear "2015" @default.
• W2177788247 type Work @default.
• W2177788247 sameAs 2177788247 @default.
• W2177788247 citedByCount "38" @default.
• W2177788247 countsByYear W21777882472015 @default.
• W2177788247 countsByYear W21777882472016 @default.
• W2177788247 countsByYear W21777882472017 @default.
• W2177788247 countsByYear W21777882472018 @default.
• W2177788247 countsByYear W21777882472019 @default.
• W2177788247 countsByYear W21777882472020 @default.
• W2177788247 countsByYear W21777882472021 @default.
• W2177788247 countsByYear W21777882472022 @default.
• W2177788247 countsByYear W21777882472023 @default.
• W2177788247 crossrefType "journal-article" @default.
• W2177788247 hasAuthorship W2177788247A5010453470 @default.
• W2177788247 hasAuthorship W2177788247A5019163181 @default.
• W2177788247 hasAuthorship W2177788247A5032891959 @default.
• W2177788247 hasAuthorship W2177788247A5054320288 @default.
• W2177788247 hasAuthorship W2177788247A5061314561 @default.
• W2177788247 hasAuthorship W2177788247A5077276053 @default.
• W2177788247 hasAuthorship W2177788247A5082003758 @default.
• W2177788247 hasAuthorship W2177788247A5085882168 @default.
• W2177788247 hasBestOaLocation W21777882471 @default.
• W2177788247 hasConcept C126322002 @default.
• W2177788247 hasConcept C134018914 @default.
• W2177788247 hasConcept C142724271 @default.
• W2177788247 hasConcept C204787440 @default.
• W2177788247 hasConcept C27081682 @default.
• W2177788247 hasConcept C2776104379 @default.
• W2177788247 hasConcept C2778163477 @default.
• W2177788247 hasConcept C2778849439 @default.
• W2177788247 hasConcept C2779620165 @default.
• W2177788247 hasConcept C2780072125 @default.
• W2177788247 hasConcept C2780745583 @default.
• W2177788247 hasConcept C2780902209 @default.
• W2177788247 hasConcept C2780948078 @default.
• W2177788247 hasConcept C2911022245 @default.
• W2177788247 hasConcept C43554185 @default.
• W2177788247 hasConcept C62746215 @default.
• W2177788247 hasConcept C71924100 @default.
• W2177788247 hasConcept C8243546 @default.
• W2177788247 hasConceptScore W2177788247C126322002 @default.
• W2177788247 hasConceptScore W2177788247C134018914 @default.
• W2177788247 hasConceptScore W2177788247C142724271 @default.
• W2177788247 hasConceptScore W2177788247C204787440 @default.
• W2177788247 hasConceptScore W2177788247C27081682 @default.
• W2177788247 hasConceptScore W2177788247C2776104379 @default.
• W2177788247 hasConceptScore W2177788247C2778163477 @default.
• W2177788247 hasConceptScore W2177788247C2778849439 @default.
• W2177788247 hasConceptScore W2177788247C2779620165 @default.

• next